arrow
T

Tuan Vu

university of south florida morsani college of medicine
H指数:46
被引数:8,584

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial

BCMA指导的mRNA car-t细胞治疗重症肌无力: 一项安慰剂对照2b期试验的探索性生物标志物分析

2026-01-090
OAAI
BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial

BCMA指导的mRNA CAR T细胞治疗重症肌无力: 一项随机,双盲,安慰剂对照的2b期试验

2026-01-090
OAAI
Long-term safety of cyclical rozanolixizumab in patients with generalized myasthenia gravis: Results from the Phase 3 MycarinG study and an open-label extension

周期性罗赞诺利珠单抗在全身型重症肌无力患者中的长期安全性:来自3期MycarinG研究及开放标签扩展研究的结果

2025-03-041
PRE
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis, A Randomized Clinical Trial

Zilucoplan治疗肌萎缩侧索硬化症的疗效与安全性:一项随机临床试验

2025-02-173
OA
Subcutaneous efgartigimod PH20 in generalized myasthenia gravis: A phase 3 randomized noninferiority study (ADAPT-SC) and interim analyses of a long-term open-label extension study (ADAPT-SC plus )
2024-09-012
PRE
Long-term safety, tolerability, and efficacy of efgartigimod in patients with generalized myasthenia gravis: Concluding analyses from the ADAPT plus study

efgartigimod在全身性重症肌无力患者中的长期安全性,耐受性和有效性: 来自ADAPT plus研究的结论分析

2023-12-010
PRE